Summary Desmethylprodine, also known as MPPP or Ro 2-0718, is an opioid analgesic initially developed in the 1940s by scientists at Hoffmann-La Roche. In the United States, the Drug Enforcement Administration (DEA) has classified Desmethylprodine as a Schedule I substance,…
Summary Crotonylfentanyl is an opioid pain reliever, structurally related to fentanyl, and a structural isomer of cyclopropylfentanyl. It has been available on the internet as a designer drug. In December 2019, the United Nations Office on Drugs and Crime (UNODC)…
Summary Cyclopropyl fentanyl is an opioid pain reliever, structurally similar to fentanyl, and has been distributed as a designer drug. Between June and December 2017, European countries reported a total of 78 fatalities linked to cyclopropyl fentanyl, with analytical confirmation…
Summary Cyclopentylfentanyl is an opioid pain reliever structurally related to fentanyl, which has been available on the internet as a designer drug, primarily in Sweden and other Nordic countries. Identifiers IUPAC name CAS Number 2088918-01-6 PubChem CID 126682248 ChemSpider 81367208…
Summary Clonitazene is an opioid pain reliever that boasts nearly triple the potency of morphine. This compound shares a kinship with etonitazene, an opioid with notably greater power. Clonitazene is not commercially available at present. Regarded as a controlled substance,…
Summary Butonitazene, categorized as a benzimidazole-derived substance with opioid properties, has been available on the internet as a designer drug. In its natural form, it exhibits moderate potency when compared to its chemical counterparts. It is commonly found as part…
Summary Brorphine is a piperidine-based opioid analgesic compound that first came to scientific attention in 2018. Initially, it was explored in research focused on functionally biased opioid compounds, with the aim of developing safer analgesics that induce less respiratory depression…
Summary Bromadoline, also known as U-47931E, is a μ-opioid receptor-selective opioid analgesic created by Upjohn in the 1970s. It falls within the range of potency between codeine and morphine, with slight superiority to pentazocine. Bromadoline shares a chemical relationship with…
Summary Butyrfentanyl, also known as butyrylfentanyl, is a potent, short-acting synthetic opioid analgesic. It serves as an analog of fentanyl, boasting roughly one-quarter of its potency. The initial reference to this compound can be traced back to a document published…
Summary BDPC, also known as bromadol, is a highly potent narcotic analgesic characterized by its unique arylcyclohexylamine chemical structure. This compound was initially developed by Daniel Lednicer at Upjohn during the 1970s.Early investigations suggested that BDPC exhibited a staggering potency,…
